Magnesium-rare earth (Mg-RE) alloys, as potential biodegradable materials, are attracting
considerable attention owing to their good mechanical properties and biodegradation …

Hyperphosphatemia, which is nearly universal in kidney failure, is accompanied by low
serum levels of vitamin D and hypocalcemia. Without treatment, severe secondary …

Results The mean change in serum phosphate was− 1.29 mg/dl (95% confidence interval,−
1.63 to− 0.96 mg/dl) in the ferric citrate hydrate group and 0.06 mg/dl (95% confidence …

Nephrogenic systemic fibrosis (NSF) is an iatrogenic scleroderma-like fibrosing systemic
disorder occurring in patients with severe or end-stage renal disease. It was established as …

A series of problems including osteopathy, abnormal serum data, and vascular calcification
associated with chronic kidney disease (CKD) are now collectively called CKD-mineral bone …

Background: Vascular calcification (VC) contributes to cardiovascular disease in
haemodialysis (HD) patients. Few controlled studies have addressed interventions to reduce …

Hyperphosphatemia is an inevitable consequence of end-stage chronic kidney disease and
is present in the majority of dialysis patients. Hyperphosphatemia is observationally and …

The use of geo-engineering materials to manage phosphorus in lakes has increased in
recent years with aluminium and lanthanum based materials being most commonly applied …

Background Chronic kidney disease–mineral and bone disorder (CKD–MBD) is a common
complication in CKD patients, particularly in those with end-stage renal disease that requires …

Despite 10 years of post‐marketing safety monitoring of the phosphate binder lanthanum
carbonate, concerns about aluminium‐like accumulation and toxicity persist. Here, we …